PIK3CA mutations can initiate pancreatic tumorigenesis and are targetable with PI3K inhibitors
about
Colon Cancer Tumorigenesis Initiated by the H1047R Mutant PI3K.HS-173, a novel PI3K inhibitor suppresses EMT and metastasis in pancreatic cancer.Acinar cell plasticity and development of pancreatic ductal adenocarcinoma.Personalized and precision medicine: integrating genomics into treatment decisions in gastrointestinal malignancies.Survival of pancreatic cancer cells lacking KRAS function.MicroRNA-203 suppresses proliferation in liver cancer associated with PIK3CA, p38 MAPK, c-Jun, and GSK3 signaling.Dual PI3K/mTOR Inhibition in Colorectal Cancers with APC and PIK3CA Mutations.MTOR inhibitor-based combination therapies for pancreatic cancer.ETV5 regulates ductal morphogenesis with Sox9 and is critical for regeneration from pancreatitis.Phosphoinositide 3-Kinase Signaling Pathway in Pancreatic Ductal Adenocarcinoma Progression, Pathogenesis, and Therapeutics.Pancreatic adenocarcinoma protein-protein interaction network analysis.
P2860
Q35919716-065D88E7-C64C-4903-8AAC-1B062A2F31F0Q37718484-293158D1-81E7-431D-9EA2-26415D617016Q38922230-5F20B520-C3E5-49DD-95D0-54E58A078A4BQ39453553-956D41D6-E3F2-4467-B138-C0F74510A80BQ42645888-E856D3DC-8B8E-4F29-9B05-1921F9C08C30Q47830356-04863B11-9C43-47F5-99EA-F13E64BED2BDQ47972738-A3BE9A68-CBC8-4EE3-861B-72BCAF015C98Q49560871-9A354256-BED2-4E78-B757-7F4EB4077AEDQ52357887-019F5D95-DB01-47E5-A153-C38DFF90E730Q54980764-045E41CC-6340-4A71-A635-DF0B1303ADA1Q55397592-CB4A0993-F2C9-4ACC-B60F-C339327CAA70
P2860
PIK3CA mutations can initiate pancreatic tumorigenesis and are targetable with PI3K inhibitors
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
PIK3CA mutations can initiate ...... argetable with PI3K inhibitors
@ast
PIK3CA mutations can initiate ...... argetable with PI3K inhibitors
@en
type
label
PIK3CA mutations can initiate ...... argetable with PI3K inhibitors
@ast
PIK3CA mutations can initiate ...... argetable with PI3K inhibitors
@en
prefLabel
PIK3CA mutations can initiate ...... argetable with PI3K inhibitors
@ast
PIK3CA mutations can initiate ...... argetable with PI3K inhibitors
@en
P2093
P2860
P356
P1433
P1476
PIK3CA mutations can initiate ...... argetable with PI3K inhibitors
@en
P2093
A A Leystra
D A Deming
D R Van De Hey
J J Jeffrey
K A Matkowskyj
P2860
P2888
P356
10.1038/ONCSIS.2015.28
P577
2015-10-05T00:00:00Z